Literature DB >> 160371

[Classification and course of cerebral infarcts on computer tomography (author's transl)].

W D Sager, G Ladurner.   

Abstract

The typical computer tomographic signs of ischaemic cerebral infarct are discussed on the basis of 631 cases. Infarcts have three typical stages. Stage I, one week, fresh infarct with signs of oedema (space-occupying lesion with an unsharp margin, slightly reduced density, lack of contrast uptake). Stage II, second to fourth week, reduction in the oedema. Frequently very marked contrast enhancement of the cortex and basal nuclei. Stage III, later than four weeks. Development of malacic cysts, with further reduction in density and size. Development of homolateral atrophy. The computer tomographic diagnosis of cerebral infarcts during Stage I is often very difficult. Distinction from infiltrating tumour is often possible only after further observation. The diagnosis of cerebral infarcts in stages II and III is possible in most cases. Haemorrhagic cerebral infarcts do not follow a temporal pattern as accurately as anaemic infarcts. They show circular increase in contrast of slowly diminishing size. The increased contrast persists considerably longer and is clearly distinguished from that in an anaemic cerebral infarct.

Entities:  

Mesh:

Year:  1979        PMID: 160371     DOI: 10.1055/s-0029-1231474

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  3 in total

1.  The "dense artery sign"--major cerebral artery thromboembolism demonstrated by computed tomography.

Authors:  B Schuknecht; M Ratzka; E Hofmann
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

Review 2.  The role of nuclear procedures in the diagnosis of intracranial disease.

Authors:  U Büll
Journal:  Neurosurg Rev       Date:  1981       Impact factor: 3.042

3.  Clinical factors associated with dementia in ischaemic stroke.

Authors:  G Ladurner; L D Iliff; H Lechner
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-02       Impact factor: 10.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.